JPS6287581A - ナフタレンスルホンアミド誘導体 - Google Patents

ナフタレンスルホンアミド誘導体

Info

Publication number
JPS6287581A
JPS6287581A JP60226405A JP22640585A JPS6287581A JP S6287581 A JPS6287581 A JP S6287581A JP 60226405 A JP60226405 A JP 60226405A JP 22640585 A JP22640585 A JP 22640585A JP S6287581 A JPS6287581 A JP S6287581A
Authority
JP
Japan
Prior art keywords
formula
solution
added
compound
remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60226405A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0558433B2 (enExample
Inventor
Hiroyoshi Hidaka
弘義 日高
Toshio Tanaka
利男 田中
Yasuo Ito
伊藤　安夫
Hideo Kato
日出男 加藤
Eiichi Etsuchu
越中　栄一
Nobuo Ogawa
小川　信男
Kazuya Mitani
見谷　一也
Shunichiro Sakurai
桜井　俊一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Japan Co Ltd
Original Assignee
Hokuriku Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokuriku Pharmaceutical Co Ltd filed Critical Hokuriku Pharmaceutical Co Ltd
Priority to JP60226405A priority Critical patent/JPS6287581A/ja
Publication of JPS6287581A publication Critical patent/JPS6287581A/ja
Publication of JPH0558433B2 publication Critical patent/JPH0558433B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP60226405A 1985-10-11 1985-10-11 ナフタレンスルホンアミド誘導体 Granted JPS6287581A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60226405A JPS6287581A (ja) 1985-10-11 1985-10-11 ナフタレンスルホンアミド誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60226405A JPS6287581A (ja) 1985-10-11 1985-10-11 ナフタレンスルホンアミド誘導体

Publications (2)

Publication Number Publication Date
JPS6287581A true JPS6287581A (ja) 1987-04-22
JPH0558433B2 JPH0558433B2 (enExample) 1993-08-26

Family

ID=16844601

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60226405A Granted JPS6287581A (ja) 1985-10-11 1985-10-11 ナフタレンスルホンアミド誘導体

Country Status (1)

Country Link
JP (1) JPS6287581A (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5245034A (en) * 1988-12-26 1993-09-14 Kiroyoshi Hidaka Compound having vessel smooth muscle relaxation activity
WO2000003746A3 (en) * 1998-07-14 2000-04-20 Brigham & Womens Hospital Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
WO2009146859A3 (en) * 2008-06-02 2010-03-18 Universiteit Gent Methods and compositions in the treatment of coronaviruses
WO2015007896A1 (fr) * 2013-07-18 2015-01-22 Neuroptis Biotech Procede pour la production d'une 1-(5-halonaphtalene-1-sulfonyl)-1h-hexahydro-1,4-diazepine et composition la comprenant

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5245034A (en) * 1988-12-26 1993-09-14 Kiroyoshi Hidaka Compound having vessel smooth muscle relaxation activity
WO2000003746A3 (en) * 1998-07-14 2000-04-20 Brigham & Womens Hospital Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
WO2009146859A3 (en) * 2008-06-02 2010-03-18 Universiteit Gent Methods and compositions in the treatment of coronaviruses
WO2015007896A1 (fr) * 2013-07-18 2015-01-22 Neuroptis Biotech Procede pour la production d'une 1-(5-halonaphtalene-1-sulfonyl)-1h-hexahydro-1,4-diazepine et composition la comprenant
FR3008698A1 (fr) * 2013-07-18 2015-01-23 Neuroptis Biotech Procede pour la production d'un actif pharmaceutique

Also Published As

Publication number Publication date
JPH0558433B2 (enExample) 1993-08-26

Similar Documents

Publication Publication Date Title
RU2114114C1 (ru) Пиразолопиримидиноновые соединения, фармацевтическая композиция и способ лечения
SU969164A3 (ru) Способ получени производных фталимидина или их солей
AU2001230426C1 (en) Therapeutic morpholino-substituted compounds
EP1404317B1 (en) 5-halo-tryptamine derivatives used as ligands of the 5-ht 6? and/or 5-ht 7? serotonin receptors
US4076711A (en) Triazolo [4,5-d]-pyrimidines
WO2018233633A1 (zh) Ssao 抑制剂
PT90622B (pt) Processo para a preparacao de derivados acilo de 2-aminobenzotiazol, uteis como agentes anti-neoplasticos
TW200301123A (en) New use
US3800039A (en) Antithrombogenic process employing substituted 6,7-dialkoxyquinazolines
RU2090562C1 (ru) Производные бензазепина или бензотиазепина
JP2003528096A (ja) デカヒドロ−イソキノリン
NO160778B (no) Analogifremgangsmaate ved fremstilling av nye antifibrinolytisk aktive tranexaminsyreestere.
CN1144529A (zh) 杂环化合物，它们的制备和应用
US5128338A (en) Imidazo [1,2-c] quinazoline compounds
SU1241986A3 (ru) Способ получени производных бензамида,их гидрохлоридов или оптических изомеров
JPH0710852A (ja) ベンズオキサジン誘導体、その製法およびその治療上の応用
JP2528451B2 (ja) ナフタレンスルホンアミド誘導体
JPS6287581A (ja) ナフタレンスルホンアミド誘導体
US4943581A (en) Isoquinolinesulfonamides
WO2024040768A1 (zh) 5-吡啶-1h-吲唑类化合物、药物组合物和应用
RU2129554C1 (ru) Производные пирролхинолинона, способ их получения, промежуточные соединения для их получения, фармацевтический состав и способ его получения
JPH0455193B2 (enExample)
TW202340145A (zh) 氘化有機化合物及其用途
JPH01311073A (ja) ベンゾチアゼピン―４―オン誘導体、その製造方法およびその医薬への応用
RU2397159C2 (ru) Способ получения производных (3-оксо-2,3-дигидро-1н-изоиндол-1-ил)-ацетилгуанидина